ART4 and pancreatic neoplasm: For example, one of the most well-known biomarkers of pancreatic cancer, glycoprotein CA19-9, is thought to be increased secondary to perverse glycosylation and was used as a biomarker for pancreatic cancer as well as various other digestive tract cancers [28].